Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Hall

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Virology|February 13, 2001
In vitro exposure to highly cytopathic HIV-1 X4 strains increases expression of mucosa-associated integrins on CD4(+) T cellsJ E Cummins, W J Bunn, S D Hall, et al.
Oral Microbiology and Immunology|January 13, 2001
Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland originY Han, C L Ventura, K P Black, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or proteinA G Pinto, J Horlander, N Chalasani, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formationD R Jones, J C Gorski, M A Hamman, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritisT S Tracy, K Krohn, D R Jones, et al.
Clinical Pharmacology and Therapeutics|October 24, 2001
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activityZ Wang, J C Gorski, M A Hamman, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.
Therapeutic Drug Monitoring|December 1, 1992
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patientsA C Rudy, J D Bradley, S I Ryan, et al.
Pharmacogenetics|February 24, 2001
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankM B Fisher, M Vandenbranden, K Findlay, et al.
Clinical Pharmacology and Therapeutics|September 5, 1998
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycinJ C Gorski, D R Jones, B D Haehner-Daniels, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Virology|February 13, 2001
In vitro exposure to highly cytopathic HIV-1 X4 strains increases expression of mucosa-associated integrins on CD4(+) T cellsJ E Cummins, W J Bunn, S D Hall, et al.
Oral Microbiology and Immunology|January 13, 2001
Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland originY Han, C L Ventura, K P Black, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or proteinA G Pinto, J Horlander, N Chalasani, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formationD R Jones, J C Gorski, M A Hamman, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritisT S Tracy, K Krohn, D R Jones, et al.
Clinical Pharmacology and Therapeutics|October 24, 2001
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activityZ Wang, J C Gorski, M A Hamman, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.
Therapeutic Drug Monitoring|December 1, 1992
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patientsA C Rudy, J D Bradley, S I Ryan, et al.
Pharmacogenetics|February 24, 2001
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankM B Fisher, M Vandenbranden, K Findlay, et al.
Clinical Pharmacology and Therapeutics|September 5, 1998
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycinJ C Gorski, D R Jones, B D Haehner-Daniels, et al.
Pageof 10